Recent Updates
Recently added Catalysts
ELVN Positive Sentiment

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...

Thursday, November 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Enliven Therapeutics, Inc. announced its participation in a fireside chat at the Jefferies London Healthcare Conference scheduled for November 19, 2024. The event will provide an opportunity for management to discuss their clinical-stage developments in small molecule therapeutics. The presentation will be accessible through a live webcast, emphasizing transparency and investor engagement in the company's activities.
Price reaction · baseline $29.55 (2024-11-06 close) · hit after-hours · clean, no other ELVN news in the window
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Enliven Therapeutics will present at a prominent event, showcasing their developments.
  • Management's participation indicates confidence in their pipeline and future prospects.
  • The live webcast allows for broader investor access and transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+259%
120-day peak, hindsight
Typical move
16.2%
average across 2 past catalysts
Cash runway
~144 mo
Minimal dilution risk
Lead asset
ELVN-002
Phase 1 · HER2-positive Breast Cancer

Full Press Release Details

BOULDER, Colo. , Nov. 7, 2024 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN ), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024 , at 9:30 a.m. GMT .
The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/ . The webcast will be archived for a period of 90 days following the conclusion of the live event.

Frequently Asked Questions

When is Enliven Therapeutics' fireside chat scheduled?

The fireside chat is on November 19, 2024, at 9:30 a.m. GMT.

Where can I watch the fireside chat live?

The chat will be available live on the Company's investor relations website.

How long will the webcast be available after the event?

The webcast will be archived for 90 days after the live event.

What is the focus of Enliven Therapeutics?

Enliven focuses on discovering and developing small molecule therapeutics.

ShareAdd on Google
Tags: ELVN Viatris Investor Conferences Healthcare Enliven Therapeutics Jefferies Conference biopharmaceuticals clinical-stage Nasdaq: ELVN
Last updated: Nov 7, 2024

Biotech snapshot

Cash runway
$895M liquidity · $6M/mo burn
~144 mo
Minimal dilution risk
Lead asset
ELVN-002Phase 1
HER2-positive Breast Cancer →

Catalyst track record

+259%
best trade around ELVN's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for ELVN.

See every catalyst's timing & PoA →